These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 33081797)

  • 21. Contrast-induced nephropathy.
    Ray S; Dutta A
    Indian Heart J; 2008; 60(2):133-8. PubMed ID: 19218722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention of contrast-induced acute kidney injury].
    Guastoni C; De Servi S; Covella P; Turri C; Gidaro B; Bellotti N; Stasi A
    G Ital Nefrol; 2012; 29 Suppl 58():S33-45. PubMed ID: 23229601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follow up for emergency department patients after intravenous contrast and risk of nephropathy.
    Hassen GW; Hwang A; Liu LL; Mualim F; Sembo T; Tu TJ; Wei DH; Johnston P; Costea A; Meletiche C; Usmani S; Barber A; Jaiswal R; Kalantari H
    West J Emerg Med; 2014 May; 15(3):276-81. PubMed ID: 24868304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
    Garcia S; Ko B; Adabag S
    Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of contrast-induced nephropathy in kidney transplant recipients.
    Haider M; Yessayan L; Venkat KK; Goggins M; Patel A; Karthikeyan V
    Transplant Proc; 2015 Mar; 47(2):379-83. PubMed ID: 25769577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast Induced Nephropathy In High Risk Patients - Myth Or Reality.
    Nabi Z; Anjum N; Rashid RM; Zahideen ZU
    J Ayub Med Coll Abbottabad; 2021; 33(4):568-571. PubMed ID: 35124909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevention of contrast-induced nephropathy.
    Au TH; Bruckner A; Mohiuddin SM; Hilleman DE
    Ann Pharmacother; 2014 Oct; 48(10):1332-42. PubMed ID: 24994723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Radiocontrast Agents in CKD and ESRD.
    Bahrainwala JZ; Leonberg-Yoo AK; Rudnick MR
    Semin Dial; 2017 Jul; 30(4):290-304. PubMed ID: 28382626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventions.
    Lee SR; Zhuo H; Zhang Y; Dahl N; Dardik A; Ochoa Chaar CI
    J Vasc Surg; 2020 Aug; 72(2):603-610.e1. PubMed ID: 31843298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Controversy of Contrast-Induced Nephropathy With Intravenous Contrast: What Is the Risk?
    Rudnick MR; Leonberg-Yoo AK; Litt HI; Cohen RM; Hilton S; Reese PP
    Am J Kidney Dis; 2020 Jan; 75(1):105-113. PubMed ID: 31473019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.
    Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease.
    Sigterman TA; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GW; Bouwman LH
    Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):386-93. PubMed ID: 26460289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant and renoprotective effects of sphingosylphosphorylcholine on contrast-induced nephropathy in rats.
    Aksu F; Aksu B; Unlu N; Karaca T; Ayvaz S; Erman H; Uzun H; Keles N; Bulur S; Unlu E
    Ren Fail; 2016 Aug; 38(7):1089-98. PubMed ID: 27309733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-induced nephropathy: the wheel has turned 360 degrees.
    Thomsen HS; Morcos SK; Barrett BJ
    Acta Radiol; 2008 Jul; 49(6):646-57. PubMed ID: 18568557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of high flow-volume intermittent hemodiafiltration during and after intervention to prevent contrast-induced nephropathy in patients with advanced chronic kidney disease: A pilot study.
    Oyamada N; Hamanaka I; Fujioka A; Iwasaku T; Minami T; Fujie H; Ueda K
    Catheter Cardiovasc Interv; 2020 Nov; 96(6):1174-1181. PubMed ID: 31802610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of contrast-induced nephropathy by limb ischemic preconditioning: underlying mechanisms and clinical effects.
    Dugbartey GJ; Redington AN
    Am J Physiol Renal Physiol; 2018 Mar; 314(3):F319-F328. PubMed ID: 28566501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease.
    Azzalini L; Laricchia A; Regazzoli D; Mitomo S; Hachinohe D; Bellini B; Demir OM; Poletti E; Maccagni D; Colombo A
    J Invasive Cardiol; 2019 Jun; 31(6):176-182. PubMed ID: 30865912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Early prevention progress of contrast induced nephropathy].
    Sang W; Yang K; Li X; Xu F; Zhang J; Wu H; Jiang T; Chen Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1174-1178. PubMed ID: 31657349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast media induced nephropathy: a literature review of the available evidence and recommendations for practice.
    Deek H; Newton P; Sheerin N; Noureddine S; Davidson PM
    Aust Crit Care; 2014 Nov; 27(4):166-71. PubMed ID: 24461960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast-induced nephropathy in percutaneous coronary interventions: pathogenesis, risk factors, outcome, prevention and treatment.
    Aurelio A; Durante A
    Cardiology; 2014; 128(1):62-72. PubMed ID: 24557146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.